Effect of whole body vibration training on pain, performance and balance in athletes with patellofemoral pain syndrome

A comparison between two protocol, whole body vibration and exercise therapy, on pain, performance and balance among 20-40 years-old athletes with patellofemoral pain syndrome

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016020624149N6

Enrollment

Registered

2016-06-16

Start date

2016-01-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patellofamoral pain syndrom. Other soft tissue disorders related to use, overuse and pressure

Interventions

Intervention 1: control group:exercise therapy .. included: patellar mobilization,rasistance training, flexibility, stretching and balance exercise. Intervention 2: Intervention group: Whole body vib

Treatment - Other

control group:exercise therapy .. included: patellar mobilization,rasistance training, flexibility, stretching and balance exercise

Intervention group: Whole body vibration Training Treatment was done 4 sessions per week for 4 weeks .Each session includes 5 sets of one minute duration with one minute rest between each two sets.

Eligibility

Sex/Gender

All

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: antro or retropatellar pain that is induced during step up and down, jumping up and running, squat, prolonged sitting; onset of symptoms has not been associated with traumatic factors; pain induction during patellar palpation; onset of symptom less than one year; the age range between 20-40years; only one leg involvement; at least one of below tests being positive: patellar apprehension test, vastus Medialis coordination test, step down eccentric test. exclusion criteria: symptoms duration for less than one month; existence of other lesions in the lower limb; surgery and fractures of lower extremity; history of patellar dislocation; usage of NSAIDs; signification injuries which affect other lower extremities joints; people who must not use WBV including acute fracture, lower limb amputation, acute damage of soft tissue, osteoporosis with vertebral fracture, acute disc herniation, recent surgery, acute edema, hip and knee endoprothesis, urinary incontinence, headache, epilepsy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Before the onset of the treatment, at the end of the treatment period, two weeks after the end of the treatment period. Method of measurement: VAS (visual analog scale).;Balance. Timepoint: Before the onset of the treatment, at the end of the treatment period, two weeks after the end of the treatment period. Method of measurement: Balance error scoring system; SEBT(star excursion balance test).;Performance. Timepoint: Before the onset of the treatment, at the end of the treatment period, two weeks after the end of the treatment period. Method of measurement: Leg press, Kujala Questionnaire.	—

Measure

Time frame

Pain. Timepoint: Before the onset of the treatment, at the end of the treatment period, two weeks after the end of the treatment period. Method of measurement: VAS (visual analog scale).;Balance. Timepoint: Before the onset of the treatment, at the end of the treatment period, two weeks after the end of the treatment period. Method of measurement: Balance error scoring system; SEBT(star excursion balance test).;Performance. Timepoint: Before the onset of the treatment, at the end of the treatment period, two weeks after the end of the treatment period. Method of measurement: Leg press, Kujala Questionnaire.

—

Secondary

Measure	Time frame
-. Timepoint: -. Method of measurement: -.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNajmeh Shadloo

School of Rehabilitation Science

shadlou.spt@gmsil.com+98 71 3627 1551

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026